Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

Combinations of drugs could hold the key to overcoming some of the biggest challenges in lung and other cancers.

State-of-the-art Novartis manufacturing facility in Indianapolis fortifies the foundation of an entirely new paradigm in pharmaceutical drug delivery.

Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.

The race is on to find a new treatment before resistance to today’s drugs becomes widespread.

Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.

We’re working to bring the hope of advanced medicine to more patients.

Ilona, a patient living with polycythemia vera, shares her experiences with this rare blood cancer

Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.

For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.